Original Source(s)
Related Content
FDA Expands Test for Gastric and Esophageal Cancers
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
-
2 min
Lyme Antibodies May Improve Test Timing
Study identifies immune markers that could support earlier diagnosis and help distinguish patients with persistent symptoms
July 10, 2026
-
3 min
Turning Routine Slides Into Molecular Maps
Could a standard pathology slide contain enough information to predict gene expression, methylation patterns, and even aspects of spatial biology?
July 13, 2026
-
8 min